封面
市場調查報告書
商品編碼
1519703

2024-2032 年按類型、數量、應用、最終用戶和地區分類的大容量注射劑市場報告

Large Volume Parenteral Market Report by Type, Volume, Application, End Users, and Region 2024-2032

出版日期: | 出版商: IMARC | 英文 143 Pages | 商品交期: 2-3個工作天內

價格

2023年,全球大容量注射劑(LVP)IMARC Group規模達98億美元。

大容量注射(LVP)是指經加熱滅菌後包裝在容量超過100ml的玻璃瓶或軟性容器中的單劑量注射劑。它是透過皮膚或其他外部邊界組織注射,將活性藥物直接給藥到血管、器官、組織或病灶內。它通常由活性成分、水混溶性或非水性載體以及緩衝劑、抗氧化劑、防腐劑、界面活性劑、抗菌劑和張力調節劑等添加劑組成。世界各地常用的 LVP 包括腹膜透析、沖洗液、血液衍生物、藥物預混劑和顯影劑。

大容量注射劑 (LVP) 市場趨勢:

全球營養不良盛行率上升、出生率上升和早產增加是促進對 LVP 需求的關鍵因素,以便為無法口服食物的患者提供大量營養。除此之外,它們還廣泛用於為接受食道阻塞、胃腸道 (GI) 疾病、癌症和潰瘍治療的患者提供必需營養素。此外,LVP 在心臟手術中已廣泛應用,以防止再灌注和血流供應限制期間心肌缺血性損傷。這與接受手術干預的患者對安全、快速和有效的給藥方法的需求不斷成長相結合,促進了市場的成長。除此之外,全球速食消費的成長導致高血壓、糖尿病、肥胖和其他代謝紊亂等非傳染性疾病的發生率上升。這反過來又對 LVP 的採用產生正面影響,LVP 是葡萄糖、胺基酸、脂質、添加電解質、微量金屬和維生素的混合物。

本報告回答的關鍵問題:

  • 迄今為止,全球大容量注射劑 (LVP) 市場表現如何,未來幾年將如何表現?
  • COVID-19 對全球大容量注射 (LVP) 市場有何影響?
  • 主要區域市場有哪些?
  • 依類型分類市場是怎麼樣的?
  • 根據成交量,市場的細分是多少?
  • 基於應用程式的市場區隔是什麼?
  • 基於最終用戶的市場區隔是什麼?
  • 產業價值鏈的各個階段是什麼?
  • 該行業的關鍵促進因素和挑戰是什麼?
  • 全球大容量注射劑 (LVP) 市場的結構如何?
  • 產業競爭程度如何?

目錄

第1章:前言

第 2 章:範圍與方法

  • 研究目的
  • 利害關係人
  • 資料來源
    • 主要資源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章:執行摘要

第 4 章:簡介

  • 概述
  • 主要行業趨勢

第 5 章:全球大容量注射 (LVP) 市場

  • 市場概況
  • 市場業績
  • COVID-19 的影響
  • 市場預測

第 6 章:市場區隔:按類型

  • 軟袋LVP
    • 市場走向
    • 市場預測
  • 塑膠瓶LVP
    • 市場走向
    • 市場預測
  • 玻璃瓶LVP
    • 市場走向
    • 市場預測

第 7 章:市場區隔:按數量

  • 100毫升-250毫升
    • 市場走向
    • 市場預測
  • 250 毫升 - 500 毫升
    • 市場走向
    • 市場預測
  • 500 毫升 - 1000 毫升
    • 市場走向
    • 市場預測
  • 1000 毫升 - 2000 毫升
    • 市場走向
    • 市場預測
  • 2000 毫升以上
    • 市場走向
    • 市場預測

第 8 章:市場區隔:按應用

  • 治療注射
    • 市場走向
    • 市場預測
  • 液體平衡注射
    • 市場走向
    • 市場預測
  • 營養注射劑
    • 市場走向
    • 市場預測

第 9 章:市場區隔:按最終用戶

  • 醫院
    • 市場走向
    • 市場預測
  • 診所
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 10 章:市場區隔:按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場走向
    • 市場細分:按國家/地區
    • 市場預測

第 11 章:SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 12 章:價值鏈分析

第 13 章:波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 14 章:價格分析

第15章:競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Albert David Ltd.
    • B. Braun Melsungen AG
    • Baxter International Inc.
    • BML Parenteral Drugs
    • Fresenius Kabi AG
    • Grifols SA
    • Otsuka Pharmaceutical Co. Ltd
    • Pharmaceutical Solutions Industry Ltd.
    • Sichuan Kelun Pharmaceutical Co., Ltd.
    • Thermo Fisher Scientific Inc.
Product Code: SR112024A5711

The global large volume parenteral (LVP) market size reached US$ 9.8 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 16.2 Billion by 2032, exhibiting a growth rate (CAGR) of 5.6% during 2024-2032.

A large volume parenteral (LVP) is a single-dose injection packaged in a glass bottle or a flexible container of more than 100ml capacity after sterilization via heat. It is injected through the skin or other external boundary tissue to directly administrate the active drug substances into the blood vessels, organs, tissues, or lesions. It generally consists of an active ingredient, water-miscible or non-aqueous vehicle, and added substances like buffers, antioxidants, preservatives, surfactants, antimicrobial agents, and tonicity adjusters. Some of the commonly available LVPs around the world are peritoneal dialysis, irrigating solutions, blood derivatives, drug premixes, and contrast agents.

Large Volume Parenteral (LVP) Market Trends:

The rising prevalence of malnutrition, growing natality rate, and increasing premature births worldwide are among the key factors catalyzing the demand for LVPs to administer a large amount of nutrients in patients who are unable to take food orally. Apart from this, they are widely used in administering essential nutrients to patients undergoing treatment for esophageal obstruction, gastrointestinal (GI) diseases, cancer, and ulcer. In addition, LVPs find extensive application in heart surgery to prevent ischemic injury to the myocardium during reperfusion and the blood flow supply restriction. This, in confluence with the escalating demand for safe, fast, and effective methods of drug administration among patients undergoing surgical interventions, is contributing to the market growth. Besides this, the growing consumption of fast food across the globe has resulted in rising instances of non-communicable diseases, such as hypertension, diabetes, obesity, and other metabolic disorders. This, in turn, is positively influencing the adoption of LVPs that are a mixture of dextrose, amino acids, lipids, added electrolytes, trace metals, and vitamins.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global large volume parenteral (LVP) market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on type, volume, application and end users.

Breakup by Type:

Soft Bag LVP

Plastic Bottle LVP

Glass Bottle LVP

Breakup by Volume:

100 ML - 250 ML

250 ML - 500 ML

500 ML - 1000 ML

1000 ML - 2000 ML

2000 ML and More

Breakup by Application:

Therapeutic Injections

Fluid Balance Injections

Nutritious Injections

Breakup by End Users:

Hospitals

Clinics

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Albert David Ltd., B. Braun Melsungen AG, Baxter International Inc., BML Parenteral Drugs, Fresenius Kabi AG, Grifols S.A, Otsuka Pharmaceutical Co. Ltd, Pharmaceutical Solutions Industry Ltd., Sichuan Kelun Pharmaceutical Co. Ltd. and Thermo Fisher Scientific Inc.

Key Questions Answered in This Report:

  • How has the global large volume parenteral (LVP) market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global large volume parenteral (LVP) market?
  • What are the key regional markets?
  • What is the breakup of the market based on the type?
  • What is the breakup of the market based on the volume?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the end users?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global large volume parenteral (LVP) market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Large Volume Parenteral (LVP) Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Soft Bag LVP
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Plastic Bottle LVP
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Glass Bottle LVP
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Volume

  • 7.1 100 ML - 250 ML
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 250 ML - 500 ML
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 500 ML - 1000 ML
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 1000 ML - 2000 ML
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 2000 ML and More
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Therapeutic Injections
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Fluid Balance Injections
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Nutritious Injections
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by End Users

  • 9.1 Hospitals
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Clinics
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Others
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Albert David Ltd.
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
    • 15.3.2 B. Braun Melsungen AG
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
    • 15.3.3 Baxter International Inc.
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
    • 15.3.4 BML Parenteral Drugs
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
    • 15.3.5 Fresenius Kabi AG
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 SWOT Analysis
    • 15.3.6 Grifols S.A
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
    • 15.3.7 Otsuka Pharmaceutical Co. Ltd
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
    • 15.3.8 Pharmaceutical Solutions Industry Ltd.
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
    • 15.3.9 Sichuan Kelun Pharmaceutical Co., Ltd.
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
    • 15.3.10 Thermo Fisher Scientific Inc.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Large Volume Parenteral Market: Major Drivers and Challenges
  • Figure 2: Global: Large Volume Parenteral Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Large Volume Parenteral Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Large Volume Parenteral Market: Breakup by Type (in %), 2023
  • Figure 5: Global: Large Volume Parenteral Market: Breakup by Volume (in %), 2023
  • Figure 6: Global: Large Volume Parenteral Market: Breakup by Application (in %), 2023
  • Figure 7: Global: Large Volume Parenteral Market: Breakup by End Users (in %), 2023
  • Figure 8: Global: Large Volume Parenteral Market: Breakup by Region (in %), 2023
  • Figure 9: Global: Large Volume Parenteral (Soft Bag LVP) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: Large Volume Parenteral (Soft Bag LVP) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: Large Volume Parenteral (Plastic Bottle LVP) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Large Volume Parenteral (Plastic Bottle LVP) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Large Volume Parenteral (Glass Bottle LVP) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Large Volume Parenteral (Glass Bottle LVP) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Large Volume Parenteral (100 ML - 250 ML) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Large Volume Parenteral (100 ML - 250 ML) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Large Volume Parenteral (250 ML - 500 ML) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Large Volume Parenteral (250 ML - 500 ML) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Large Volume Parenteral (500 ML - 1000 ML) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Large Volume Parenteral (500 ML - 1000 ML) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: Large Volume Parenteral (1000 ML - 2000 ML) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: Large Volume Parenteral (1000 ML - 2000 ML) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: Large Volume Parenteral (2000 ML and More) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: Large Volume Parenteral (2000 ML and More) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Global: Large Volume Parenteral (Therapeutic Injections) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Global: Large Volume Parenteral (Therapeutic Injections) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Global: Large Volume Parenteral (Fluid Balance Injections) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Global: Large Volume Parenteral (Fluid Balance Injections) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Global: Large Volume Parenteral (Nutritious Injections) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: Global: Large Volume Parenteral (Nutritious Injections) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: Global: Large Volume Parenteral (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: Global: Large Volume Parenteral (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: Global: Large Volume Parenteral (Clinics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: Global: Large Volume Parenteral (Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: Global: Large Volume Parenteral (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: Global: Large Volume Parenteral (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: North America: Large Volume Parenteral Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: North America: Large Volume Parenteral Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: United States: Large Volume Parenteral Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: United States: Large Volume Parenteral Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: Canada: Large Volume Parenteral Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: Canada: Large Volume Parenteral Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: Asia-Pacific: Large Volume Parenteral Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: Asia-Pacific: Large Volume Parenteral Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: China: Large Volume Parenteral Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: China: Large Volume Parenteral Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: Japan: Large Volume Parenteral Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: Japan: Large Volume Parenteral Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: India: Large Volume Parenteral Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: India: Large Volume Parenteral Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: South Korea: Large Volume Parenteral Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: South Korea: Large Volume Parenteral Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: Australia: Large Volume Parenteral Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: Australia: Large Volume Parenteral Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: Indonesia: Large Volume Parenteral Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: Indonesia: Large Volume Parenteral Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: Others: Large Volume Parenteral Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: Others: Large Volume Parenteral Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: Europe: Large Volume Parenteral Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: Europe: Large Volume Parenteral Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: Germany: Large Volume Parenteral Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: Germany: Large Volume Parenteral Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: France: Large Volume Parenteral Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: France: Large Volume Parenteral Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: United Kingdom: Large Volume Parenteral Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: United Kingdom: Large Volume Parenteral Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: Italy: Large Volume Parenteral Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: Italy: Large Volume Parenteral Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 69: Spain: Large Volume Parenteral Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 70: Spain: Large Volume Parenteral Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: Russia: Large Volume Parenteral Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 72: Russia: Large Volume Parenteral Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 73: Others: Large Volume Parenteral Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 74: Others: Large Volume Parenteral Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: Latin America: Large Volume Parenteral Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 76: Latin America: Large Volume Parenteral Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 77: Brazil: Large Volume Parenteral Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 78: Brazil: Large Volume Parenteral Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 79: Mexico: Large Volume Parenteral Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 80: Mexico: Large Volume Parenteral Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 81: Others: Large Volume Parenteral Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 82: Others: Large Volume Parenteral Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 83: Middle East and Africa: Large Volume Parenteral Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 84: Middle East and Africa: Large Volume Parenteral Market: Breakup by Country (in %), 2023
  • Figure 85: Middle East and Africa: Large Volume Parenteral Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 86: Global: Large Volume Parenteral Industry: SWOT Analysis
  • Figure 87: Global: Large Volume Parenteral Industry: Value Chain Analysis
  • Figure 88: Global: Large Volume Parenteral Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Large Volume Parenteral Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Large Volume Parenteral Market Forecast: Breakup by Type (in Million US$), 2024-2032
  • Table 3: Global: Large Volume Parenteral Market Forecast: Breakup by Volume (in Million US$), 2024-2032
  • Table 4: Global: Large Volume Parenteral Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 5: Global: Large Volume Parenteral Market Forecast: Breakup by End Users (in Million US$), 2024-2032
  • Table 6: Global: Large Volume Parenteral Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 7: Global: Large Volume Parenteral Market: Competitive Structure
  • Table 8: Global: Large Volume Parenteral Market: Key Players